Literature DB >> 15160396

Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha.

Mieke Buntinx1, Ellen Gielen, Paul Van Hummelen, Jef Raus, Marcel Ameloot, Paul Steels, Piet Stinissen.   

Abstract

Cytokines, such as interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha), can initiate dual effects resulting in either cell growth or cell death. In this study, the human oligodendroglial cell lines HOG and MO3.13 were used as a model to study the molecular mechanisms of cytokine-induced cell death in human oligodendrocytes. We have previously shown that TNF-alpha and IFN-gamma induce apoptosis in both oligodendroglial cell lines within 72 hr. In the present study, the cell death pathways operating within these cells were further investigated at the gene expression level. Both cell lines express a broad repertoire of caspases and apoptosis-related genes. Some of these genes are specifically up-regulated by cytokine treatment; e.g., caspase-1 is up-regulated by IFN-gamma. In addition to direct cytotoxic effects, IFN-gamma and TNF-alpha also enhance the expression of Fas, TNFR1, and MHC class I molecules in both cell lines. This suggests that cytokines can make oligodendrocytes more vulnerable to different cell death pathways in an inflammatory environment. cDNA microarray analysis of the HOG cell line revealed that TNF-alpha induces genes that regulate apoptosis, survival, inflammation, cell metabolism, and cell signaling. The data suggest that oligodendroglial cells activate both death and survival pathways upon cytokine challenges. However, the survival pathways seem to be unable to compete with the death signal after more than 24 hr of cytokine treatment. These results may contribute to the development of therapeutic strategies aimed at interfering with cytokine-induced cell death of oligodendrocytes in patients with multiple sclerosis. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160396     DOI: 10.1002/jnr.20117

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  16 in total

Review 1.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

Review 2.  Oligodendrocyte-microglia cross-talk in the central nervous system.

Authors:  Laura Peferoen; Markus Kipp; Paul van der Valk; Johannes M van Noort; Sandra Amor
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

3.  cFLIP is critical for oligodendrocyte protection from inflammation.

Authors:  D C Tanner; A Campbell; K M O'Banion; M Noble; M Mayer-Pröschel
Journal:  Cell Death Differ       Date:  2015-01-30       Impact factor: 15.828

Review 4.  Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury.

Authors:  Akihiro Shindo; Anna C Liang; Takakuni Maki; Nobukazu Miyamoto; Hidekazu Tomimoto; Eng H Lo; Ken Arai
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

5.  Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.

Authors:  Sunita K Patel; Andrew L Wong; F Lennie Wong; Elizabeth Crabb Breen; Arti Hurria; Mackenzie Smith; Christine Kinjo; I Benjamin Paz; Laura Kruper; George Somlo; Joanne E Mortimer; Melanie R Palomares; Michael R Irwin; Smita Bhatia
Journal:  J Natl Cancer Inst       Date:  2015-06-22       Impact factor: 13.506

6.  Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.

Authors:  Kirsten S Evonuk; Brandi J Baker; Ryan E Doyle; Carson E Moseley; Christine M Sestero; Bryce P Johnston; Patrizia De Sarno; Andrew Tang; Igor Gembitsky; Sandra J Hewett; Casey T Weaver; Chander Raman; Tara M DeSilva
Journal:  J Immunol       Date:  2015-06-12       Impact factor: 5.422

7.  Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line.

Authors:  Maria Podbielska; Zdzisław M Szulc; Ewa Kurowska; Edward L Hogan; Jacek Bielawski; Alicja Bielawska; Narayan R Bhat
Journal:  J Lipid Res       Date:  2016-09-13       Impact factor: 5.922

8.  The control of oligodendrocyte bioenergetics by interferon-gamma (IFN-γ) and Src homology region 2 domain-containing phosphatase-1 (SHP-1).

Authors:  Scott B Minchenberg; Paul T Massa
Journal:  J Neuroimmunol       Date:  2017-10-28       Impact factor: 3.478

Review 9.  Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis.

Authors:  T Zeis; N Schaeren-Wiemers
Journal:  J Mol Neurosci       Date:  2008-02-16       Impact factor: 3.444

Review 10.  Glial Purinergic Signaling in Neurodegeneration.

Authors:  Marie J Pietrowski; Amr Ahmed Gabr; Stanislav Kozlov; David Blum; Annett Halle; Kevin Carvalho
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.